Martin Péč

501 total citations
17 papers, 432 citations indexed

About

Martin Péč is a scholar working on Cancer Research, Molecular Biology and Surgery. According to data from OpenAlex, Martin Péč has authored 17 papers receiving a total of 432 indexed citations (citations by other indexed papers that have themselves been cited), including 11 papers in Cancer Research, 10 papers in Molecular Biology and 5 papers in Surgery. Recurrent topics in Martin Péč's work include Cancer, Lipids, and Metabolism (10 papers), Metabolism, Diabetes, and Cancer (6 papers) and Lipoproteins and Cardiovascular Health (5 papers). Martin Péč is often cited by papers focused on Cancer, Lipids, and Metabolism (10 papers), Metabolism, Diabetes, and Cancer (6 papers) and Lipoproteins and Cardiovascular Health (5 papers). Martin Péč collaborates with scholars based in Slovakia, Czechia and Australia. Martin Péč's co-authors include Peter Kubatka, Karol Kajo, Bianka Bojková, Monika Kassayová, Marián Adamkov, Desanka Výbohová, Peter Orendáš, Ján Mojžíš, Peter Kružliak and Martin Kello and has published in prestigious journals such as Nutrition, Journal of Cellular and Molecular Medicine and European Journal of Nutrition.

In The Last Decade

Martin Péč

17 papers receiving 426 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Martin Péč Slovakia 11 218 90 54 54 53 17 432
Andrea Kapinová Slovakia 12 295 1.4× 101 1.1× 106 2.0× 50 0.9× 52 1.0× 23 618
K. Kolanjiappan India 8 240 1.1× 68 0.8× 105 1.9× 28 0.5× 32 0.6× 8 536
Katarzyna Owczarek Poland 13 170 0.8× 42 0.5× 118 2.2× 60 1.1× 31 0.6× 25 453
Joel Reinhardt United States 11 303 1.4× 68 0.8× 80 1.5× 20 0.4× 54 1.0× 17 636
Yujie Guo China 10 186 0.9× 33 0.4× 39 0.7× 67 1.2× 48 0.9× 37 434
Sona Uramova Slovakia 7 164 0.8× 63 0.7× 47 0.9× 30 0.6× 20 0.4× 7 319
Pei‐Sheng Lee Taiwan 13 227 1.0× 29 0.3× 51 0.9× 35 0.6× 21 0.4× 25 457
Antonio Ramón Martín Spain 6 276 1.3× 58 0.6× 31 0.6× 37 0.7× 47 0.9× 6 574
Ying Yao United States 12 196 0.9× 31 0.3× 25 0.5× 14 0.3× 46 0.9× 23 487
Joanne F. Doleman United Kingdom 9 319 1.5× 28 0.3× 52 1.0× 23 0.4× 18 0.3× 12 489

Countries citing papers authored by Martin Péč

Since Specialization
Citations

This map shows the geographic impact of Martin Péč's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Martin Péč with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Martin Péč more than expected).

Fields of papers citing papers by Martin Péč

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Martin Péč. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Martin Péč. The network helps show where Martin Péč may publish in the future.

Co-authorship network of co-authors of Martin Péč

This figure shows the co-authorship network connecting the top 25 collaborators of Martin Péč. A scholar is included among the top collaborators of Martin Péč based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Martin Péč. Martin Péč is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

17 of 17 papers shown
1.
Bojková, Bianka, Karol Kajo, Peter Kubatka, et al.. (2019). Metformin and melatonin improve histopathological outcome of NMU-induced mammary tumors in rats. Pathology - Research and Practice. 215(4). 722–729. 4 indexed citations
2.
Bojková, Bianka, Karol Kajo, Terézia Kisková, et al.. (2017). Metformin and melatonin inhibit DMBA-induced mammary tumorigenesis in rats fed a high-fat diet. Anti-Cancer Drugs. 29(2). 128–135. 16 indexed citations
3.
Kubatka, Peter, Sona Uramova, Martin Kello, et al.. (2017). Antineoplastic effects of clove buds (Syzygium aromaticum L.) in the model of breast carcinoma. Journal of Cellular and Molecular Medicine. 21(11). 2837–2851. 65 indexed citations
4.
Kubatka, Peter, Martin Kello, Karol Kajo, et al.. (2016). Oregano demonstrates distinct tumour-suppressive effects in the breast carcinoma model. European Journal of Nutrition. 56(3). 1303–1316. 53 indexed citations
5.
Kubatka, Peter, Andrea Kapinová, Martin Kello, et al.. (2015). Fruit peel polyphenols demonstrate substantial anti-tumour effects in the model of breast cancer. European Journal of Nutrition. 55(3). 955–965. 55 indexed citations
6.
Kapinová, Andrea, Peter Kubatka, Martin Péč, et al.. (2015). Chlorella pyrenoidosa, young barley and fruit peel polyphenols in rat breast cancer model - the effects on plasma lipid metabolism. Biologia. 70(2). 268–272. 4 indexed citations
7.
Bojková, Bianka, Peter Orendáš, Karol Kajo, et al.. (2015). Role of high-fat diet on the effect of pioglitazone and melatonin in a rat model of breast cancer. European Journal of Cancer Prevention. 25(5). 395–403. 6 indexed citations
8.
Bojková, Bianka, Peter Orendáš, Peter Kubatka, et al.. (2014). Positive and negative effects of glitazones in carcinogenesis: Experimental models vs. clinical practice. Pathology - Research and Practice. 210(8). 465–472. 10 indexed citations
9.
Kubatka, Peter, Bianka Bojková, Monika Kassayová, et al.. (2014). Combination of Pitavastatin and melatonin shows partial antineoplastic effects in a rat breast carcinoma model. Acta Histochemica. 116(8). 1454–1461. 27 indexed citations
10.
Kassayová, Monika, Nikita Bobrov, Ladislav Strojný, et al.. (2014). Preventive effects of probiotic bacteria Lactobacillus plantarum and dietary fiber in chemically-induced mammary carcinogenesis.. PubMed. 34(9). 4969–75. 47 indexed citations
11.
Kubatka, Peter, Andrea Kapinová, Peter Kružliak, et al.. (2014). Antineoplastic effects of Chlorella pyrenoidosa in the breast cancer model. Nutrition. 31(4). 560–569. 47 indexed citations
12.
Orendáš, Peter, Peter Kubatka, Bianka Bojková, et al.. (2014). Melatonin potentiates the anti‐tumour effect of pravastatin in rat mammary gland carcinoma model. International Journal of Experimental Pathology. 95(6). 401–410. 37 indexed citations
13.
Kubatka, Peter, Jozef Škarda, Karol Kajo, et al.. (2012). Preventive effects of fluvastatin in rat mammary carcinogenesis. European Journal of Cancer Prevention. 22(4). 352–357. 13 indexed citations
14.
Kubatka, Peter, Karol Kajo, Martin Péč, et al.. (2011). Rosuvastatin in the chemoprevention of N-methyl-N-nitrosourea-induced mammary carcinogenesis in female rats. Acta veterinaria. 61(5-6). 445–460. 6 indexed citations
15.
Bojková, Bianka, Martin Péč, Peter Kubatka, et al.. (2011). Metabolic Effects of Pioglitazone in Chemically-Induced Mammary Carcinogenesis in Rats. Pathology & Oncology Research. 17(4). 887–892. 5 indexed citations
16.
Kubatka, Peter, Peter Solár, Karol Kajo, et al.. (2011). Antitumor effects of atorvastatin in the chemoprevention of rat mammary carcinogenesis. Biologia. 66(4). 727–734. 12 indexed citations
17.
Bojková, Bianka, Karol Kajo, Martin Péč, et al.. (2010). Pioglitazone in chemically induced mammary carcinogenesis in rats. European Journal of Cancer Prevention. 19(5). 379–384. 25 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026